TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,284,000 | -48.1% | 345,791 | -7.8% | 0.03% | -46.7% |
| Q4 2021 | $17,883,000 | -26.7% | 374,910 | +2.1% | 0.06% | -34.1% |
| Q3 2021 | $24,385,000 | +3.3% | 367,081 | +21.3% | 0.09% | +8.3% |
| Q2 2021 | $23,607,000 | +12.0% | 302,578 | +35.7% | 0.08% | -3.4% |
| Q1 2021 | $21,087,000 | -35.4% | 222,931 | -16.8% | 0.09% | -42.4% |
| Q4 2020 | $32,667,000 | +36.7% | 268,091 | -2.0% | 0.15% | +11.0% |
| Q3 2020 | $23,899,000 | +68.5% | 273,571 | +24.6% | 0.14% | +41.7% |
| Q2 2020 | $14,183,000 | – | 219,584 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |